1. Market Research
  2. > All Companies
  3. > Inovio Pharmaceuticals, Inc. - Product Pipeline Review - 2015

Inovio Pharmaceuticals, Inc. - Product Pipeline Review - 2015

  • June 2015
  • -
  • Global Markets Direct
  • -
  • 71 pages

Inovio Pharmaceuticals, Inc. - Product Pipeline Review - 2015

Summary

Global Markets Direct’s, ‘Inovio Pharmaceuticals, Inc. - Product Pipeline Review - 2015’, provides an overview of the Inovio Pharmaceuticals, Inc.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Inovio Pharmaceuticals, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Inovio Pharmaceuticals, Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Inovio Pharmaceuticals, Inc.’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the Inovio Pharmaceuticals, Inc.’s pipeline products

Reasons to buy

- Evaluate Inovio Pharmaceuticals, Inc.’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Inovio Pharmaceuticals, Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Inovio Pharmaceuticals, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Inovio Pharmaceuticals, Inc. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Inovio Pharmaceuticals, Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Inovio Pharmaceuticals, Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

Table Of Contents

Inovio Pharmaceuticals, Inc. - Product Pipeline Review - 2015
Table of Contents
Table of Contents 2
List of Tables 6
List of Figures 6
Inovio Pharmaceuticals, Inc. Snapshot 7
Inovio Pharmaceuticals, Inc. Overview 7
Key Information 7
Key Facts 7
Inovio Pharmaceuticals, Inc. - Research and Development Overview 8
Key Therapeutic Areas 8
Inovio Pharmaceuticals, Inc. - Pipeline Review 11
Pipeline Products by Stage of Development 11
Pipeline Products - Monotherapy 12
Pipeline Products - Out-Licensed Products 13
Out-Licensed Products/Combination Treatment Modalities 14
Inovio Pharmaceuticals, Inc. - Pipeline Products Glance 15
Inovio Pharmaceuticals, Inc. - Clinical Stage Pipeline Products 15
Phase II Products/Combination Treatment Modalities 15
Phase I Products/Combination Treatment Modalities 16
Inovio Pharmaceuticals, Inc. - Early Stage Pipeline Products 17
Preclinical Products/Combination Treatment Modalities 17
Inovio Pharmaceuticals, Inc. - Drug Profiles 18
VGX-3100 18
Product Description 18
Mechanism of Action 18
RandD Progress 18
INO-3112 19
Product Description 19
Mechanism of Action 19
RandD Progress 19
INO-8000 20
Product Description 20
Mechanism of Action 20
RandD Progress 20
FVH-1 21
Product Description 21
Mechanism of Action 21
RandD Progress 21
INO-1400 22
Product Description 22
Mechanism of Action 22
RandD Progress 22
INO-3106 23
Product Description 23
Mechanism of Action 23
RandD Progress 23
INO-3401 24
Product Description 24
Mechanism of Action 24
RandD Progress 24
INO-3510 25
Product Description 25
Mechanism of Action 25
RandD Progress 25
INO-3605 26
Product Description 26
Mechanism of Action 26
RandD Progress 26
INO-3609 27
Product Description 27
Mechanism of Action 27
RandD Progress 27
INO-4212 28
Product Description 28
Mechanism of Action 28
RandD Progress 28
PENNVAX-B 29
Product Description 29
Mechanism of Action 29
RandD Progress 29
PENNVAX-G 31
Product Description 31
Mechanism of Action 31
RandD Progress 31
PENNVAX-GP 32
Product Description 32
Mechanism of Action 32
RandD Progress 32
VRC-01 33
Product Description 33
Mechanism of Action 33
RandD Progress 33
chikungunya vaccine 36
Product Description 36
Mechanism of Action 36
RandD Progress 36
Clostridium difficile vaccine 37
Product Description 37
Mechanism of Action 37
RandD Progress 37
dengue [serotypes 1,2,3,4] (tetravalent) vaccine 38
Product Description 38
Mechanism of Action 38
RandD Progress 38
Gene Therapy for Ebola Virus Infections 39
Product Description 39
Mechanism of Action 39
RandD Progress 39
influenza [H7N9] vaccine 40
Product Description 40
Mechanism of Action 40
RandD Progress 40
influenza [strain A/H3N2] vaccine 41
Product Description 41
Mechanism of Action 41
RandD Progress 41
INO-4500 42
Product Description 42
Mechanism of Action 42
RandD Progress 42
INO-5150 43
Product Description 43
Mechanism of Action 43
RandD Progress 43
INO-7103 44
Product Description 44
Mechanism of Action 44
RandD Progress 44
INO-7105 45
Product Description 45
Mechanism of Action 45
RandD Progress 45
MAV-12 46
Product Description 46
Mechanism of Action 46
RandD Progress 46
Monoclonal Antibodies for Cancer and Immunology 47
Product Description 47
Mechanism of Action 47
RandD Progress 47
RSQ-15 48
Product Description 48
Mechanism of Action 48
RandD Progress 48
Vaccine for Cancer 49
Product Description 49
Mechanism of Action 49
RandD Progress 49
Vaccines for Neurological Disorders 50
Product Description 50
Mechanism of Action 50
RandD Progress 50
Inovio Pharmaceuticals, Inc. - Pipeline Analysis 51
Inovio Pharmaceuticals, Inc. - Pipeline Products by Target 51
Inovio Pharmaceuticals, Inc. - Pipeline Products by Route of Administration 53
Inovio Pharmaceuticals, Inc. - Pipeline Products by Molecule Type 54
Inovio Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action 55
Inovio Pharmaceuticals, Inc. - Recent Pipeline Updates 56
Inovio Pharmaceuticals, Inc. - Dormant Projects 65
Inovio Pharmaceuticals, Inc. - Discontinued Pipeline Products 66
Discontinued Pipeline Product Profiles 66
mifepristone 66
VGX-410C 66
Inovio Pharmaceuticals, Inc. - Company Statement 67
Inovio Pharmaceuticals, Inc. - Locations And Subsidiaries 69
Head Office 69
Other Locations and Subsidiaries 69
Appendix 70
Methodology 70
Coverage 70
Secondary Research 70
Primary Research 70
Expert Panel Validation 70
Contact Us 70
Disclaimer 71

List of Tables
Inovio Pharmaceuticals, Inc., Key Information 7
Inovio Pharmaceuticals, Inc., Key Facts 7
Inovio Pharmaceuticals, Inc. - Pipeline by Indication, 2015 9
Inovio Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2015 11
Inovio Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2015 12
Inovio Pharmaceuticals, Inc. - Out-Licensed Products in Pipeline, 2015 13
Inovio Pharmaceuticals, Inc. - Out-Licensed Products/ Combination Treatment Modalities, 2015 14
Inovio Pharmaceuticals, Inc. - Phase II, 2015 15
Inovio Pharmaceuticals, Inc. - Phase I, 2015 16
Inovio Pharmaceuticals, Inc. - Preclinical, 2015 17
Inovio Pharmaceuticals, Inc. - Pipeline by Target, 2015 52
Inovio Pharmaceuticals, Inc. - Pipeline by Route of Administration, 2015 53
Inovio Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2015 54
Inovio Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2015 55
Inovio Pharmaceuticals, Inc. - Recent Pipeline Updates, 2015 56
Inovio Pharmaceuticals, Inc. - Dormant Developmental Projects,2015 65
Inovio Pharmaceuticals, Inc. - Discontinued Pipeline Products, 2015 66
Inovio Pharmaceuticals, Inc., Subsidiaries 69

List of Figures
Inovio Pharmaceuticals, Inc. - Pipeline by Top 10 Indication, 2015 9
Inovio Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2015 11
Inovio Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2015 12
Inovio Pharmaceuticals, Inc. - Pipeline by Top 10 Target, 2015 51
Inovio Pharmaceuticals, Inc. - Pipeline by Top 10 Route of Administration, 2015 53
Inovio Pharmaceuticals, Inc. - Pipeline by Top 10 Molecule Type, 2015 54

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Clare

+1 718 303 2384

Purchase Reports From Reputable Market Research Publishers

H5N1 Infection (Avian Influenza) - Pipeline Review, H1 2015

H5N1 Infection (Avian Influenza) - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • June 2015
  • by Global Markets Direct

H5N1 Infection (Avian Influenza) - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘H5N1 Infection (Avian Influenza) - Pipeline Review, H1 2015’, provides an overview of the H5N1 Infection ...

Hepatitis A - Pipeline Review, H1 2015

Hepatitis A - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • June 2015
  • by Global Markets Direct

Hepatitis A - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Hepatitis A - Pipeline Review, H1 2015’, provides an overview of the Hepatitis A’s therapeutic pipeline. This report provides ...

Yellow Fever - Pipeline Review, H1 2015

Yellow Fever - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • April 2015
  • by Global Markets Direct

Yellow Fever - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Yellow Fever - Pipeline Review, H1 2015’, provides an overview of the Yellow Fever’s therapeutic pipeline. This report ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.